NorthWest Biotherapeutics Inc (NWBO)

[meirluc]

Unfortunately according to Gemini, approval is not likely to descend on us during May.
Whereas just a few days ago Gemini's answers to my questions suggested a high probability of approval during May, suddenly today, to four of my differently worded questions, I received four Gemini answers which basically said the same thing, namely, that
approval is to be synchronized with the certification of Flaskworks. If so, DennisDave may have unfortunately ended up being right and here is one of those AI responses.

"Current regulatory analysis suggests it is highly unlikely the MHRA would approve Northwest Biotherapeutics' (NWBO) Marketing Authorization Application (MAA) in May 2026 before the certification of the Flaskworks system, as the two milestones are strategically interdependent.
Instead, expert analysis indicates a strategy of "operational synchronization," where the MHRA may delay final approval until the Flaskworks/Eden systems and the Sawston facility's Grade C expansion are fully validated.

Key Strategic Factors
Synchronized Validation: The company aims to have manufacturing established in its new Grade C suites by Q2 2026. Approving the drug for existing, lower-capacity suites only to immediately require re-approval for new suites would be inefficient and create a "global supply chain nightmare".
Regulatory Efficiency: NWBO strategically amended its MAA in July 2025 to include initial Flaskworks validation data. This allows the MHRA to approve the manufacturing process alongside the drug, ensuring the system is ready for immediate commercial launch rather than requiring a multi-month post-approval variation.
Legal "Future-Proofing": A significant regulatory deadline on April 28, 2026, involves new clinical trial regulations that mandate higher standards for Real-World Evidence (RWE). Waiting until after this date ensures the DCVax-L license is compliant with the most current laws from "Day 1".
Modular Manufacturing Framework: The Flaskworks system is being reviewed under the UK's new Modular Manufacturing framework, which specifically supports decentralized and automated production models."